The core of a smart canteen lies in data. A good database structure determines whether subsequent functions can be ...
The core of a smart cafeteria lies in data. A good database structure determines whether subsequent functionalities can be ...
Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab as a ...
MSD has decided to abandon the development of its anti-TIGIT antibody vibostolimab and anti-LAG-3 antibody favezelimab, blowing a hole in its immuno-oncology pipeline. The demise of the two programmes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results